Greg Lovins
Analyst · Baird. Please go ahead
Thanks, Mitch and hello, everybody. I'll first provide an update today on a performance against our long-term goals and then walking through our fourth quarter performance and our outlook for 2021. Slide 11 of our supplemental presentation materials provides an update on our progress against the five-year targets that we communicated in 2017. And recall that this represents our third set of long-term goals after meeting or beating our previous two sets. The consistent execution of our key strategies enables us to continue delivering against our targets with an overriding focus on delivering GDP plus growth in top quartile returns on capital over the long term. As you can see, we are largely on track to deliver once again. Over the four-year period, sales growth on a constant currency basis is up nearly 4% annually with organic growth of 2% annually. While both are below our initial target largely due to the late stage recession in this cycle, we are achieving our objective of growing above GDP over this period. Reporting operating margin was 11.6% in 2020 or 12.4% on an adjusted basis, up significantly from roughly 10% in 2016. Additionally, our EBITDA margin was above 15 percent in 2020. And as always, our focus will continue to be the optimal balance of growth, margins, and capital efficiency to drive incremental EVA over the long term. Our adjusted earnings per share is up over 15% annually largely driven by the solid top line growth and strong margin expansion. And our return on total capital came in at 18% for 2020, above our 17% target reflecting top quartile performance relative to our capital market peers. And our balance sheet remains strong with our net debt to EBITDA ratio below the low end of our target range, giving us ample capacity to continue executing our strategies. Our consistent progress towards achieving these long term goals reflects the diversity of our end markets, the strength of our position in those markets, and our resilience and agility as an organization to adjust course when needed. At the same time that we communicated our financial goals through 2021, we also laid out a five-year plan for capital allocation which you can see on slide 12. We're tracking well against this plan starting with strong cash flow generation. We've deployed a total of $3.4 billion over the last four years, allocating it in line with our long term plan. And clearly our current leverage position gives us ample capacity to continue investing organically as well as through strategic acquisitions while continuing to return cash to shareholders in a disciplined way. Now let me turn to the fourth quarter. Overall, financial results were strong with adjusted earnings per share of $2.27, up 31% versus prior year, reflecting better than expected top and bottom line performance in each of our segments. We grew sales by 12.3% or 3.2% on an organic basis. And currency translation increased reported sales growth by 2.3 points. In the extra week in the fourth quarter increase reported sales by 4.9%. Adjusted operating margin increased by 160 basis points to 13.5% reflecting significant margin expansion in each operating segment. Our tight near-term cost controls in this environment combined with a flow through benefit from a volume surge late in the quarter. As well as our ongoing structural productivity actions in a benefit from the 53rd week drove strong margin expansion in Q4. And we realized $18 million of restructuring savings net of transition costs in the quarter due in part to the long term actions that we accelerated into 2020 particularly in RBIS. And for the year we generated $548 million of free cash flow up 7% compared to 2019. Total capital and IT spending came in at $219 million higher than recent expectations as we accelerated investment in our high value categories particularly in RFID. And as mentioned previously our balance sheet remains strong with a net debt-to-adjusted EBITDA ratio at year-end of '17. And as we've proven our ability to manage through the compounding global crisis we face this year we've been putting that leverage capacity to work. For the year we deployed $350 million for strategic acquisitions as well as returned $301 million to shareholders through the combination of share repurchases and a growing dividend. Now, let me turn to segment results for the quarter. Label and graphic material sales increased by 3.6% on an organic basis driven by the net effect increased by 3.6% on an organic basis driven by the net effect of volume and mix. And sales improve sequentially across all regions. Label and Packaging Material sales were up mid-single digits organically, benefiting from a late quarter pandemic related surge in demand. In specialty and durable label categories grew high single digits but low to mid-single digit growth in the base business. Graphics and Reflective sales were down mid-single digits, reflecting modest sequential improvement after rebounding significantly in Q3 following the sharp decline in Q2 as a result of the government mandated lockdowns time. Looking into segment sales trends by region in Q4. In North America, LGM sales were up mid-single digits organically for the quarter with the LPM of up high single digits while Graphics declined modestly. In Europe, LGM sales for the quarter are roughly flat on an organic basis, reflecting strong sequential improvement. LPM was up low single digits while Graphics declined by high single digits. And in Asia, LGM was up low single digits for the quarter on an organic basis with relatively consistent growth across the countries. LGM’s adjusted operating margin increased 210 basis points to 15.4%, as the benefits of productivity, favorable volume and mix in raw material deflation net of pricing, more than offset higher employee related costs. Shifting now to Retail Branding and Information Solutions, RBIS sales were up 11.6% ex-currency, and up 3.1% on an organic basis, reflecting continued improvement in both the high value categories and the base business as retailers geared up for the holiday season early on in the quarter. High-value categories were up nearly 20% organically, with enterprise-wide RFID sales up 55% ex-currency and up 21% on an organic basis. And the base business was down low- to mid-single digits. Looking at the total apparel business, the value channel outperformed all the other channels and was up 40% organically for the quarter. And adjusted operating margin for the segment increased 210 basis points to 15.7%. The significant margin expansion was driven by productivity initiatives, including accelerated structural actions and temporary cost controls, along with the better-than-anticipated volumes. These benefits were partially offset by higher employee-related costs. Turning to the Industrial and Healthcare Materials segment, sales increased by 0.7% on an organic basis as a high-single-digit increase for industrial categories, reflecting continued sequential improvement in transfer automotive applications in particular, was partially offset by a mid-single-digit decline in health care categories. Adjusted operating margin increased by 210 basis points to 12.3% as the benefits from higher volume and productivity more than offset higher employee-related costs. So turning now to our outlook for 2021, we anticipate adjusted earnings per share to be in the range of $7.65 to $8.05. We've outlined some of the key contributing factors to this guidance on slide 18 of our supplemental presentation materials. We estimate that organic sales growth will be approximately 3% to 7%, with the midpoint of that range reflecting continued recovery in our end markets across the segments. The extra week in the fourth quarter of 2020 will be a headwind of little more than a point to reported sales growth, and a roughly $0.15 headwind to EPS for the full year. We anticipate Q1 will benefit by roughly $0.10 based on the shift in the calendar more than offset by a roughly $0.25 to headwind down in Q4. Based on recent rates currency translation is a roughly 2 point tailwind to reported sales growth with an estimated $25 million benefit to operating income. And we estimate incremental pre-tax savings from restructuring net of transition costs of roughly $70 million in 2021. Given we previously accelerated some 2021 actions into the second half of 2020, the vast majority of the savings represent a carryover impact from actions that we initiated last year. And we also expect a majority of the approximately $135 million in temporary cost savings we delivered in 2020 to be a headwind as markets recover. Moving to our outlook on the tax rate based on current regulations we expect both the GAAP and adjusted tax rates will be in the mid-20s for the full year. And we expect free cash flow to be more than $600 million in 2021. And finally we estimate average shares outstanding assuming dilution of $83 million to $84 million. In summary, despite the challenging environment we're pleased with the strategic and financial progress we made against our long-term goals in 2020. And we're confident in our ability to continue to deliver exceptional value through our strategies for long-term profitable growth and disciplined capital allocation. And now we'll open up the call for your questions.